Bausch Health Joseph Papa, Bausch Health Joe Papa
Bausch Health Christina Ackermann

Christina Ackermann joined the company as Executive Vice President, General Counsel, in August 2016. In this role, she is responsible for Bausch Health’s worldwide legal affairs, compliance, global security and enterprise risk management. In June 2020, she was named Head of Commercial Operations. Prior to Bausch Health, Ackermann was part of the Novartis group of companies for 14 years, most recently serving as Senior Vice President, General Counsel for Alcon, where she was responsible for the for the legal, intellectual property and compliance functions. Previously, she served as Global Head, Legal and General Counsel at Sandoz, the generics division of Novartis, from 2007 to 2012. She joined Novartis Pharma in 2002 as Head, Legal Technical Operations and Ophthalmics, and assumed the role of Head Legal General Medicine in July 2005. Before Novartis, Ackermann served in Associate General Counsel roles with Bristol Myers Squibb and DuPont Pharmaceuticals, as well as in private practice, where she focused on securities, and mergers & acquisitions. Ackermann attended York University, Toronto, Canada, for her undergraduate studies, focusing initially on fine arts and later moving into mathematics and political sciences. Ackermann also attended Queen's University, Kingston, Canada, where she obtained her LL.B., and King’s College at the University of London, UK, where she obtained a Post Graduate Diploma in EC Competition Law.

Bausch Health Thomas Appio
Bausch Health Paul Herendeen

Paul Herendeen joined the company in August 2016. Previously, he served as Executive Vice President and Chief Financial Officer of Zoetis Inc., the global animal health company, for two years. From 2005 to 2013 and from 1998 to 2001, Herendeen served as CFO at Warner Chilcott, a specialty pharmaceuticals company. He rejoined Warner Chilcott after four years as Executive Vice President and CFO of MedPointe, a privately held health care company, where he served as CFO from 2001 until 2005. Prior to that, Herendeen spent nine years as a principal investor at Dominion Income Management and Cornerstone Partners, where he worked on investments as well as mergers & acquisitions for the firms and their portfolio companies. He spent the early part of his career in banking and public accounting, holding various positions with the investment banking group of Oppenheimer & Company, the capital markets group of Continental Bank Corporation and as a senior auditor with Arthur Andersen & Company. Herendeen earned a Master of Business Administration (MBA) from the University of Virginia's Darden School of Business, and holds a bachelor's degree in Business Administration from Boston College.

Bausch Health Robert Spurr
Bausch Health Dennis Asharin
Bausch Health Joseph Gordon
Bausch Health Jeff Hartness
Bausch Health Scott Hirsch
Bausch Health Barbara Purcell
Bausch Health Tage Ramakrishna

Dr. Tage Ramakrishna has been with the company since 2011 and has more than 15 years of experience in the pharmaceutical industry, including positions at Progenics Pharmaceuticals, Nycomed in Zurich Switzerland, and Insmed Pharmaceuticals.

Bausch Health Kelly Webber
Bausch Health Louis Yu

Louis Yu joined the company in October 2016 with more than 30 years of leadership experience in the Quality and R&D functions of generic and branded pharmaceutical companies. He was Executive Vice President, Global Quality & Compliance at Perrigo Company from 2006 to 2016.